Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:404-414

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hers, I.
Right arrow Articles by Akkerman, J. W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hers, I.
Right arrow Articles by Akkerman, J. W. N.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:404-414.)
© 1998 American Heart Association, Inc.


Original Contributions

Differential Involvement of Tyrosine and Serine/Threonine Kinases in Platelet Integrin {alpha}IIbß3 Exposure

Ingeborg Hers; José Donath; Gijsbert van Willigen; ; Jan Willem N. Akkerman

From the Department of Haematology, University Hospital Utrecht, and the Institute for Biomembranes, Utrecht University, Utrecht, the Netherlands.

Correspondence to Dr J.W.N. Akkerman, Department of Haematology, University Hospital Utrecht, PO Box 85500, 3508 GA Utrecht, the Netherlands. E-mail j.w.n.akkerman{at}lab.azu.nl

Abstract—The relative contributions of protein tyrosine kinases (PTKs) and protein kinase C isoenzymes (PKCs), a family of serine/threonine kinases, in integrin {alpha}IIbß3 (glycoprotein IIb/IIIa) exposure are the subject of much controversy. In the present study we measured the effect of the PTK inhibitor herbimycin A and the PKC inhibitor bisindolylmaleimide I on 125I-fibrinogen binding to {alpha}IIbß3 and on aggregation/secretion induced by different agonists. Dose-response studies showed complete inhibition of {alpha}IIbß3 exposure by 30 µmol/L (ADP stimulation) and 35 to 40 µmol/L ({alpha}-thrombin stimulation) herbimycin A. In contrast, inhibition of exposure by bisindolylmaleimide I varied from none (for ADP and epinephrine), to 30% (for platelet-activating factor), and to {approx}80% (for {alpha}-thrombin). Studies with a submaximal dose of herbimycin A ({approx}50% inhibition of the ADP-response) and a maximal dose of bisindolylmaleimide I showed that optical aggregation had a similar sensitivity to the inhibitors as {alpha}IIbß3 exposure with minimal interference by secreted ADP. Thus, the relative contributions of tyrosine and serine/threonine kinases in {alpha}IIbß3 exposure and aggregation differ among the different agonists, with an exclusive role for PTKs in ADP- and epinephrine-induced responses and a role for both PTKs and PKCs in responses induced by platelet-activating factor and {alpha}-thrombin.


Key Words: integrin {alpha}IIbß3 • fibrinogen binding • aggregation • human platelets • protein phosphorylation




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. W. Hunter, C. MacKintosh, and I. Hers
Protein Kinase C-mediated Phosphorylation and Activation of PDE3A Regulate cAMP Levels in Human Platelets
J. Biol. Chem., May 1, 2009; 284(18): 12339 - 12348.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Gundewar, J. W. Calvert, J. W. Elrod, and D. J. Lefer
Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2462 - H2471.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W.-Y. Wang, Y.-C. Wu, and C.-C. Wu
Prevention of Platelet Glycoprotein IIb/IIIa Activation by 3,4-Methylenedioxy-beta-Nitrostyrene, A Novel Tyrosine Kinase Inhibitor
Mol. Pharmacol., October 1, 2006; 70(4): 1380 - 1389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. T. Dorsam, S. Kim, S. Murugappan, S. Rachoor, H. Shankar, J. Jin, and S. P. Kunapuli
Differential requirements for calcium and Src family kinases in platelet GPIIb/IIIa activation and thromboxane generation downstream of different G-protein pathways
Blood, April 1, 2005; 105(7): 2749 - 2756.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Azam, S. S. Andrabi, K. E. Sahr, L. Kamath, A. Kuliopulos, and A. H. Chishti
Disruption of the Mouse {micro}-Calpain Gene Reveals an Essential Role in Platelet Function
Mol. Cell. Biol., March 15, 2001; 21(6): 2213 - 2220.
[Abstract] [Full Text]


Home page
CirculationHome page
M. T. Santos, A. Moscardo, J. Valles, M. Martinez, M. Pinon, J. Aznar, M. J. Broekman, and A. J. Marcus
Participation of Tyrosine Phosphorylation in Cytoskeletal Reorganization, {alpha}IIb{beta}3 Integrin Receptor Activation, and Aspirin-Insensitive Mechanisms of Thrombin-Stimulated Human Platelets
Circulation, October 17, 2000; 102(16): 1924 - 1930.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Hers, J. Donath, P. E. M. H. Litjens, G. van Willigen, and J.-W. N. Akkerman
Inhibition of Platelet Integrin {alpha}IIb{beta}3 by Peptides That Interfere With Protein Kinases and the {beta}3 Tail
Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1651 - 1660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Jung and M. Moroi
Signal-transducing Mechanisms Involved in Activation of the Platelet Collagen Receptor Integrin alpha 2beta 1
J. Biol. Chem., March 10, 2000; 275(11): 8016 - 8026.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Polanowska-Grabowska and A. R. L. Gear
Activation of Protein Kinase C Is Required for the Stable Attachment of Adherent Platelets to Collagen but Is Not Needed for the Initial Rapid Adhesion Under Flow Conditions
Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 3044 - 3054.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Calvete
Platelet Integrin GPIIb/IIIa: Structure-Function Correlations. An Update and Lessons from Other Integrins2
Experimental Biology and Medicine, October 2, 1999; 222(1): 29 - 38.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Hackeng, M. Huigsloot, M. W. Pladet, H. K. Nieuwenhuis, H. J. M. van Rijn, and J.-W. N. Akkerman
Low-Density Lipoprotein Enhances Platelet Secretion Via Integrin-{alpha}IIbß3–Mediated Signaling
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 239 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Kroner, K. Eybrechts, and J.-W. N. Akkerman
Dual Regulation of Platelet Protein Kinase B
J. Biol. Chem., September 1, 2000; 275(36): 27790 - 27798.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Maschberger, M. Bauer, J. Baumann-Siemons, K. J. Zangl, E. V. Negrescu, A. J. Reininger, and W. Siess
Mildly Oxidized Low Density Lipoprotein Rapidly Stimulates via Activation of the Lysophosphatidic Acid Receptor Src Family and Syk Tyrosine Kinases and Ca2+ Influx in Human Platelets
J. Biol. Chem., June 16, 2000; 275(25): 19159 - 19166.
[Abstract] [Full Text] [PDF]